Yehoda M Martei, MD, MSCE

faculty photo
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
3400 Civic Center Blvd.
Philadelphia, PA 19104
Education:
BA (Biology)
Harvard University, 2005.
MD (Medicine)
Yale University School of Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2018.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Kizub DA, Naik S, Abogan AA, Pain D, Sammut S, Shulman LN, Martei YM.: Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda. Oncologist 27(11): 958-970, Nov 2023 Notes: DOI: 10.1093/oncolo/oyac143

Motlokwa PK, Tsima BM, Martei YM, Ralefala T, Galebole F, Stephens-Shields AJ, Grover S, Gross R.: Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa. JCO Glob Oncol 8: e2100439, Aug 2022 Notes: DOI: 10.1200/GO.21.00439

Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, Gross R, Shulman LN, Grover S, DeMichele A.: Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy. JCO Glob Oncol 8: e2200016. May 2022 Notes: DOI: 10.1200/GO.22.00016

Martei YM, Grover S, Narasimhamurthy M, Setlhako DI, Ayane GN, Ralefala TB, Chiyapo SP, Gross R, DeMichele A, Shulman LN : Relative dose intensity and pathologic response rates in HIV-infected and HIV-uninfected breast cancer patients who received neoadjuvant chemotherapy. Journal of Clinical Oncology 18(15 Suppl e19140): e2200016, May 2022.

Martei YM, Clark AS.: Navigating Systemic Therapeutic Options for First-Line Metastatic Hormone Receptor-Positive, ERBB2-Negative Breast Cancer Treatment. JAMA Netw Open 5: e224380, Apr 2022.

Martei YM, Dauda B, Vanderpuye V.: Correction: Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer 22(1): 306, Mar 2022.

Razis E, Kassapian M, Andriakopoulou C, Martei YM, Zurn SJ, Hammad N, Romero Y, Dafni U, Ilbawi AM, Trapani D.: Essential medicines list in national cancer control plans: a secondary analysis from a global study. Lancet Oncol 23(3): e144-154, Mar 2022.

Martei YM, Dauda B, Vanderpuye V.: Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer 22: 203, Feb 2022.

Ralefala T, Mokokwe L, Jammalamadugu S, Legobere D, Motlhwa WS, Oyekunle AA, Grover S, Barg FK, Shulman LN, Martei YM: Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis. Oncologist 26(12): e2200-e2208, Dec 2021.

Davey S, Grover S, Bilker WB, Setlhako DI, Ralefala TB, Manshimba P, Gross R, DeMichele A, Shulman LN, Martei YM.: Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana. BMJ Open 11(7): e049574, Jul 2021.

back to top
Last updated: 01/13/2023
The Trustees of the University of Pennsylvania